Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis

被引:177
作者
Lum, JJ
Cohen, OJ
Nie, ZL
Weaver, JG
Gomez, TS
Yao, XJ
Lynch, D
Pilon, AA
Hawley, N
Kim, JE
Chen, ZX
Montpetit, M
Sanchez-Dardon, J
Cohen, EA
Badley, AD
机构
[1] Mayo Clin & Mayo Fdn, Div Infect Dis, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Sect Immunol Res, Rochester, MN 55905 USA
[3] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada
[4] NIAID, NIH, Bethesda, MD 20892 USA
[5] Univ Montreal, Dept Microbiol & Immunol, Lab Retrovirol Humaine, Montreal, PQ H3C 3J7, Canada
[6] Immunex Corp, Seattle, WA USA
[7] Hlth Canada, Natl HIV AIDS Labs, Ottawa, ON K1A 0L2, Canada
关键词
D O I
10.1172/JCI200316233
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The absence of immune defects that occurs in the syndrome of long-term nonprogressive (LTNP) HIV infection offers insights into the pathophysiology of HIV-induced immune disease. The (H[F/S]RIG)(2) domain of viral protein R (Vpr) induces apoptosis and may contribute to HIV-induced T cell depletion. We demonstrate a higher frequency of R77Q Vpr mutations in patients with LTNP than in patients with progressive disease. In addition, T cell infections using vesicular stomatitis virus G (VSV-G) pseudotyped HIV-1 Vpr R77Q result in less (P = 0.01) T cell death than infections using wild-type Vpr, despite similar levels of viral replication. Wild-type Vpr-associated events, including procaspase-8 and -3 cleavage, loss of mitochondrial transmembrane potential (Deltapsi(m)), and DNA fragmentation factor activation are attenuated by R77Q Vpr. These data highlight the pathophysiologic role of Vpr in HIV-induced immune disease and suggest a novel mechanism of LTNP.
引用
收藏
页码:1547 / 1554
页数:8
相关论文
共 30 条
[1]   Mechanisms of HIV-associated lymphocyte apoptosis [J].
Badley, AD ;
Pilon, AA ;
Landay, A ;
Lynch, DH .
BLOOD, 2000, 96 (09) :2951-2964
[2]   In vivo analysis of Fas/FasL interactions in HIV-infected patients [J].
Badley, AD ;
Dockrell, DH ;
Algeciras, A ;
Ziesmer, S ;
Landay, A ;
Lederman, MM ;
Connick, E ;
Kessler, H ;
Kuritzkes, D ;
Lynch, DH ;
Roche, P ;
Yagita, H ;
Paya, CV .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :79-87
[3]   Dynamic correlation of apoptosis and immune activation during treatment of HIV infection [J].
Badley, AD ;
Parato, K ;
Cameron, DW ;
Kravcik, S ;
Phenix, BN ;
Ashby, D ;
Kumar, A ;
Lynch, DH ;
Tschopp, J ;
Angel, JB .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (05) :420-432
[4]  
Baudouin F, 1999, CYTOMETRY, V38, P127
[5]   LONG-TERM HIV-1 INFECTION WITHOUT IMMUNOLOGICAL PROGRESSION [J].
BUCHBINDER, SP ;
KATZ, MH ;
HESSOL, NA ;
OMALLEY, PM ;
HOLMBERG, SD .
AIDS, 1994, 8 (08) :1123-1128
[6]   Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells:: Implications for the development of therapeutic strategies [J].
Chun, TW ;
Justement, JS ;
Moir, S ;
Hallahan, CW ;
Ehler, LA ;
Liu, SY ;
McLaughlin, M ;
Dybul, M ;
Mican, JM ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :253-258
[7]  
Cohen GD, 1997, AM J GERIAT PSYCHIAT, V5, P1
[8]   GENOMIC STRUCTURE OF AN ATTENUATED QUASI-SPECIES OF HIV-1 FROM A BLOOD-TRANSFUSION DONOR AND RECIPIENTS [J].
DEACON, NJ ;
TSYKIN, A ;
SOLOMON, A ;
SMITH, K ;
LUDFORDMENTING, M ;
HOOKER, DJ ;
MCPHEE, DA ;
GREENWAY, AL ;
ELLETT, A ;
CHATFIELD, C ;
LAWSON, VA ;
CROWE, S ;
MAERZ, A ;
SONZA, S ;
LEARMONT, J ;
SULLIVAN, JS ;
CUNNINGHAM, A ;
DWYER, D ;
DOWTON, D ;
MILLS, J .
SCIENCE, 1995, 270 (5238) :988-991
[9]   PROGRAMMED CELL-DEATH AND AIDS - SIGNIFICANCE OF T-CELL APOPTOSIS IN PATHOGENIC AND NONPATHOGENIC PRIMATE LENTIVIRAL INFECTIONS [J].
ESTAQUIER, J ;
IDZIOREK, T ;
DEBELS, F ;
BARRESINOUSSI, F ;
HURTREL, B ;
AUBERTIN, AM ;
VENET, A ;
MEHTALI, M ;
MUCHMORE, E ;
MICHEL, P ;
MOUTON, Y ;
GIRARD, M ;
AMEISEN, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9431-9435
[10]   Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors [J].
Franceschi, C ;
Franceschini, MG ;
Boschini, A ;
Trenti, T ;
Nuzzo, C ;
Castellani, G ;
Smacchia, C ;
DeRienzo, B ;
Roncaglia, R ;
Portolani, M ;
Pietrosemoli, P ;
Meacci, M ;
Pecorari, M ;
Sabbatini, A ;
Malorni, W ;
Cossarizza, A .
CELL DEATH AND DIFFERENTIATION, 1997, 4 (08) :815-823